Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Nilotinib Capsules

Approval Number

国药准字HJ20140333

CompanyNovartis Pharma Schweiz AG

Registration Date

August 29, 2023

Previous Approval Numbers

H20140333

Drug Information

Generic Name

尼洛替尼胶囊

Trade Name

达希纳

Dosage Form

胶囊剂

Strength

200mg

Drug Type

化学药品

Registration Date

August 29, 2023

Expiry Date

August 28, 2028

Company Information

Applicant Company

Company NameNovartis Pharma Schweiz AG

Company Address

6343 Risch, Switzerland

Manufacturing Company

Company NameNovartis Pharma Stein AG

Company Address

Schaffhauserstrasse 4332 Stein, Switzerland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy